MAP 2020 : Molecular analysis for precision oncology congress
MAP is the leading congress in precision medicine in oncology in Europe, established by key opinion leaders in the field.
Clinical trial: immuno-PET optimization protocol
Immuno-PET optimization protocol: anti-ACE pre-targeting Type of study: Feasibility study Pathology: HER2 negative, ACE positive metastatic breast cancer Investigator :
